Prrx1 potentiated stemness acquisition of non-stem tumor cells (NSTCs) and stemness maintenance of glioma stem cells (GSCs) by upregulating GSC markers including CD133, SOX2, and OCT4. This evidence concerns the gene POU5F1 and central nervous system cancer.